Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 924 trials across Europe, recruiting first
Study of ARI-0001 Cells for Children and Adolescents with Resistant or Refractory Acute Lymphoblastic Leukemia
SpainStudy on Durvalumab and Stereotactic Body Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer
FinlandStudy on Lutetium-177-PSMA and 18F-PSMA-1007 for Patients with Oligo-metastatic Hormone Sensitive Prostate Cancer
CyprusStudy of Amivantamab and Cetrelimab for Patients with Metastatic Non-Small Cell Lung Cancer
ItalyStudy on Zolbetuximab and mFOLFOX6 for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
BelgiumStudy Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma
FranceStudy of Lurbinectedin and Pembrolizumab for Patients with Relapsed Small Cell Lung Cancer
SpainSafety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors
HungaryStudy Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumStudy on Treosulfan, Fludarabine Phosphate, and Thiotepa for Patients with Myelofibrosis Undergoing Haplo-identical Transplantation
FranceStudy on Reducing Chemotherapy for Patients with Low-Risk Localized Gastroesophageal Cancer Using Docetaxel, Oxaliplatin, Calcium Folinate, and Fluorouracil
FranceStudy of BB-1701 for Patients with HER2-positive or HER2-low Metastatic Breast Cancer
FranceThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
